Company / Goodwill
Amgen Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$18.7B
FY2025
5-year range
$14.9B / $18.7B
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
#6 of 76
Health Care
What the data says
Among 76 Health Care companies, Amgen is in the top 8% for goodwill. Goodwill has increased for 5 consecutive years, from $14.7B in FY2020 to $18.7B in FY2025.
Based on SEC 10-K filings.
$18.7B in FY2025 with a 5-year CAGR of +4.9%. Top quartile in the Health Care sector.
Remained stable around $18.7B over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +6.4%
- 5-Year CAGR
- +4.9%
- 10-Year CAGR
- -
Sector benchmark
Top 8% in Health CareTop 8% of 76This company $18.7B Sector average $3.9B
▼
+376.8% above sector average
Key checks
Key Insights
- Amgen's goodwill has grown for 5 consecutive years.
- 5-year CAGR of +4.9%, indicating consistent growth.
- In FY2025, goodwill increased 0.2% year-over-year.
- Ranks #6 out of 76 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.7B | +0.2% |
| FY2024 | $18.6B | +0.0% |
| FY2023 | $18.6B | +20.0% |
| FY2022 | $15.5B | +4.3% |
| FY2021 | $14.9B | +1.4% |
| FY2020 | $14.7B | -0.1% |
| FY2019 | $14.7B | +0.0% |
| FY2018 | $14.7B | -0.4% |
| FY2017 | $14.8B | +0.0% |
| FY2016 | $14.8B | +0.1% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026